Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement and cancer.

E Barrett-Connor1

  • 1Department of Community and Family Medicine, University of California San Diego, La Jolla.

British Medical Bulletin
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Postmenopausal women using estrogen for noncontraceptive reasons face increased reproductive cancer risks. Adding progestin may prevent endometrial cancer, but breast and ovarian cancer risks remain uncertain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Sex and Age Differences in the Association of Blood Pressure and Hypertension with Cognitive Function in the Elderly: The Rancho Bernardo Study.

The journal of prevention of Alzheimer's disease·2017
Same author

Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Kyphosis and Sleep Characteristics in Older Persons: The Rancho Bernardo Study.

Journal of sleep disorders and management·2017
Same author

Blood pressure trajectories in relation to cardiovascular mortality: The Rancho Bernardo Study.

Journal of human hypertension·2017
Same author

Association between Dietary Sodium Intake and Cognitive Function in Older Adults.

The journal of nutrition, health & aging·2017
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Area of Science:

  • Reproductive endocrinology
  • Oncology
  • Hormone therapy research

Background:

  • Postmenopausal hormone therapy is increasingly used for noncontraceptive benefits.
  • Estrogen therapy carries known risks for reproductive cancers.

Purpose of the Study:

  • To evaluate the association between noncontraceptive estrogen use and reproductive cancer risk in postmenopausal women.
  • To assess the impact of progestin addition on these risks.

Main Methods:

  • Review of existing studies on estrogen replacement therapy and cancer incidence.
  • Analysis of endometrial, breast, and ovarian cancer risk data associated with hormone use.

Main Results:

  • Unopposed estrogen triples endometrial cancer risk within years, a risk that persists post-discontinuation.

Related Experiment Videos

  • Progestin addition appears to mitigate endometrial cancer risk.
  • Long-term estrogen use may be linked to a small but significant increase in breast cancer risk.
  • The impact on ovarian cancer risk remains largely unknown.

    • Conclusions:

    • Postmenopausal women using noncontraceptive estrogen require careful consideration of elevated reproductive cancer risks.
    • Informed decision-making regarding hormone therapy should include awareness of both known and uncertain cancer risks.
    • Progestin co-administration is a potential strategy to reduce endometrial cancer risk.